![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 925.00 | 924.50 | 925.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLIN
RNS Number : 4839B
JPMorgan Securities Plc
11 February 2022
AMENDMENT
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: J.P. Morgan Securities Plc (b) Name of offeror/offeree in relation to whose relevant Clinigen Group plc securities this form relates: Use a separate form for each offeror/offeree -------------------------------------------------- (c) Name of the party to the offer with which exempt principal financial adviser to Triton Investment Management trader is connected: -------------------------------------------------- (d) Date dealing undertaken: 9 February 2022 -------------------------------------------------- (e) In addition to the company in 1(b) above, is the exempt N/A principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" -------------------------------------------------- 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit security securities paid/received paid/received 0.1p ordinary Purchase 905,277 9.2005 GBP 9.1800 GBP Sale 217,768 9.1925 GBP 9.1795 GBP ----------------- ------------------------ ----------------------- ----------------------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit security e.g. CFD e.g. opening/closing a securities long/short position, increasing/reducing a long/short position 0.1p ordinary Equity Swap Decrease Long 7,209 9.1865 GBP Decrease Short 3,476 9.1795 GBP 136,383 9.1800 GBP Increase Long 7,770 9.1803 GBP 3,730 9.1818 GBP 9,116 9.1848 GBP Increase Short 2,466 9.1801 GBP 301 9.1839 GBP 829,419 9.1846 GBP 4,643 9.1907 GBP 695 9.1928 GBP 402 9.2004 GBP 2,781 9.2005 GBP Opening a short position 68 9.1976 GBP -------------------- ------------------------- ------------------------- --------------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry date Option money relevant description purchasing, securities price per e.g. paid/ security e.g. call selling, to which unit American, received per option varying etc. option European unit relates etc. (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) e.g. subscription, conversion 3. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None Date of disclosure: 11 February 2022 Contact name: Alwyn Basch ----------------- Telephone number: 020 7742 7407 -----------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FERGPUUCPUPPGCG
(END) Dow Jones Newswires
February 11, 2022 09:41 ET (14:41 GMT)
1 Year Clinigen Chart |
1 Month Clinigen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions